METTL1 and neoplasm: METTL1 expression consistently increased from primary to metastatic human tumours (Fig. 1C), and high expression of METTL1 showed worse prognosis in Cambridge, Stockholm, and Taylor cohorts [6, 46] (Fig. 1D; Supplementary Fig. S1B).